IRIS
BRUNO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.385
EU - Europa 3.603
AS - Asia 2.302
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 12
SA - Sud America 7
AF - Africa 5
Totale 11.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.354
CN - Cina 2.104
IE - Irlanda 1.215
UA - Ucraina 566
IT - Italia 461
FI - Finlandia 434
DE - Germania 347
SE - Svezia 248
GB - Regno Unito 147
SG - Singapore 126
FR - Francia 87
BE - Belgio 37
CA - Canada 30
IN - India 27
JP - Giappone 16
CZ - Repubblica Ceca 15
AU - Australia 11
CH - Svizzera 10
EU - Europa 10
IR - Iran 9
NL - Olanda 8
TR - Turchia 7
RO - Romania 6
RU - Federazione Russa 6
MU - Mauritius 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
HK - Hong Kong 3
LV - Lettonia 3
MD - Moldavia 3
AZ - Azerbaigian 2
LK - Sri Lanka 2
PL - Polonia 2
RS - Serbia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
VN - Vietnam 1
Totale 11.327
Salva come PNG Salva come JPEG
Città #
Dublin 1.214
Chandler 1.181
Jacksonville 722
Nanjing 601
Boardman 415
Ashburn 364
Princeton 257
Nanchang 234
Lawrence 224
Wilmington 211
Shenyang 189
Hebei 177
Beijing 176
Changsha 159
Helsinki 159
Medford 154
Jiaxing 128
Ann Arbor 126
Milan 117
Shanghai 104
New York 85
Tianjin 85
Hangzhou 82
Pavia 67
Singapore 67
Woodbridge 55
Norwalk 44
Seattle 43
Verona 39
Los Angeles 37
Brussels 35
Fairfield 31
Houston 28
Pune 24
Toronto 22
Washington 21
Dallas 18
Kunming 16
Ningbo 16
San Francisco 15
Munich 14
Tokyo 14
Zhengzhou 13
Brno 12
Des Moines 12
Auburn Hills 11
Jinan 11
Rome 11
Vicenza 11
Piscataway 10
Berlin 8
Chicago 8
Guangzhou 8
Redwood City 8
Taizhou 8
Tappahannock 8
Dearborn 7
London 7
Orange 7
Varese 6
Zurich 6
Bergamo 5
Brescia 5
Caccamo 5
Falls Church 5
Rozzano 5
Canberra 4
Cinisello Balsamo 4
Como 4
Florence 4
Fuzhou 4
Haikou 4
Motta Visconti 4
Sacramento 4
Turin 4
Baoding 3
Besana in Brianza 3
Campomorone 3
Changchun 3
Chisinau 3
Falkenstein 3
Frankfurt am Main 3
Laives 3
Lanzhou 3
Magenta 3
Melbourne 3
Paceco 3
Riga 3
Weimar 3
Zanjan 3
Acqui Terme 2
Andover 2
Angri 2
Baku 2
Basel 2
Belgrade 2
Bientina 2
Borås 2
Buccinasco 2
Canyon Country 2
Totale 8.068
Salva come PNG Salva come JPEG
Nome #
Hepatitis B virus genotype distribution in HIV-1 coinfected patients 228
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 124
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 95
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 93
The Pavia consensus statement 87
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 81
Challenges for hepatitis C patients coinfected with HIV. 81
Host factors affecting the outcome of treatment of hepatitis C 80
Mice and rabbits: Animal models for HIV-1 infection 79
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 75
Aggressive daily interferon therapy in HIV-HCV coinfected patients 75
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. 74
Management of hepatitis C in human immunodeficiency virus-infected patients 71
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 69
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT 68
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 68
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 67
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 67
Will direct-acting antivirals make a difference in HIV-HCV coinfected patients? 67
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 67
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a 66
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 66
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 66
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 66
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 65
Malattie Infettive 65
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 65
Treatment of echinococcal abdominal cysts 65
Hepatotoxicity and nelfinavir: a meta-analysis 64
Ultrasound in the diagnosis of gallbladder ascariasis 64
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. 64
Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C 64
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 64
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts. 62
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 62
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 61
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 61
Reply about: Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis 61
Clinical management of hepatic abscesses in HIV patients 61
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas. 61
Portal Hypertension in Childhood Bilateral Wilms' Tumor Survivor: An Excellent Indication for TIPS 61
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 60
Transfusion-transmitted virus infection in HIV-1-seropositive patients 60
The role of the rs12979860 polymorphism of the interleukin-28b as a predictor of sustained virological response after antiviral therapy in patients with hemophilia and chronic hepatitis C 60
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. 60
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 60
Malattie Infettive 59
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 59
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 58
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 58
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. 58
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 58
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 58
The Management of Hepatitis B/HIV1 coinfected patients starting their first HAART regimen Treating two infections for the price of one drug?. 58
Effect of the IL-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in HIV co-infected patients 58
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 58
YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient. 56
Prophylaxis and treatment of hepatitis B in immunocompromised patients 56
Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. 56
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 56
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 56
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 56
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. 56
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis. 56
Percutaneous drainage of echinococcal cysts (PAIR--puncture, aspiration, injection, reaspiration): results of a worldwide survey for assessment of its safety and efficacy. WHO-Informal Working Group on Echinococcosis-Pair Network 55
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 55
Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV coinfected patients 55
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 55
Epatite Cronica C: l'ottimizzazione della terapiaCapitolo:efficacia terapeutica , aderenza alla terapia e riduzione di dose in pazienti con epatite cronica C 54
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 54
Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. 54
Infettivologia e Parassitologia Vol I A-I 54
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 54
Pathogenesis of liver damage in HCV-HIV patients 54
Echinococcal liver cysts: treatment with echo-guided percutaneous puncture PAIR for echinococcal liver cysts 54
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 54
Pathogenesis of liver damage in HCV-HIV patients. 53
Epatiti Virali Acute 53
Is second biopsy helpful in the diagnosis of hepatocellular carcinoma with a first negative biopsy? 53
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin. 53
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 53
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. 53
Endocardite, pericarditee miocardite 52
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 52
The Value of Culture of Pus Via Percutaneous Drainage Under Sonographic Guidance In Diagnosis and Therapy of Pyogenic Liver-abscess 52
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 52
Antibiotic stewardship and empirical antibiotic treatment: How can they get along? 52
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 52
High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus 51
Hepatotoxicity and antiretroviral therapy with protease inhibitors: a review 51
Epatocarcinoma nei soggetti HIV positivi 51
Natural history of chronic hepatitis B in co-infected patients. 51
Infezioni dell’apparatogastrointestinale 51
Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naive patients with chronic hepatitis C: a randomized, controlled study 51
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 50
Viral excretion in the cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. 50
Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a. 50
Infettivologia e ParassitologiaVol II J-Z 50
Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles 50
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. 50
Totale 6.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020710 0 0 0 123 20 138 10 114 7 203 85 10
2020/20211.198 120 93 80 102 15 146 11 198 75 161 149 48
2021/20221.036 33 13 21 11 21 26 23 66 68 15 144 595
2022/20233.398 370 225 39 269 309 347 7 182 1.445 50 100 55
2023/20241.550 155 235 67 81 211 337 80 114 13 59 69 129
2024/2025529 98 328 97 6 0 0 0 0 0 0 0 0
Totale 11.659